JPRN-UMIN000032702已完成未知
Prospective, randomized, open-label,clinical trial comparing the effects of olmesartan and imidapril on blood pressure, endothelial function and makers for obesity/oxidative stress/chronic kidney diseases - Effects of olmesartan and imidapril on endothelial function
ational Defense Medical College0 个研究点目标入组 30 人开始时间: 2018年5月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Poor-controlled hypertension (DBP>110) 2) Poor-controlled diabetes (HbA1c>8.0 %) 3) Secondary hypertension 4) History of stroke, acute coronary syndrome or any cardiovascular diseases needed for inpatient-treatments within 6 months 5) Either level of aspartate aminotransaminase or alanine aminotransferase exceeds three-fold of the normal limits. 6) End stage renal disease 7) Symptomatic (NYHA III or IV) congestive heart failure 8) Malignancies or other diseases with poor prognosis 9) Subjects whose doctor in charge do not agree to join the trial
研究者
相似试验
已完成
4 期
Prospective, randomized, open-label,clinical trial comparing the effects of olmesartan/azelnidipine and candesartan/amlodipine on blood pressure, endothelial function and makers for obesity/oxidative stress/chronic kidney diseasesHypertensionJPRN-UMIN000005684ational Defense Medical College30
已完成
4 期
Prospective, randomized, open-label,clinical trial comparing the effects of telmisartan and valsartan on blood pressure, endothelial function and makers for obesity/oxidative stress/chronic kidney diseasesHypertensionJPRN-UMIN000005685ational Defense Medical College30
已完成
不适用
Prospective, randomized, open-label,clinical trial comparing the effects of hydrogen tablet and placebo on blood and urine makers for cardiovascular diseasescardiovascular disease, diabetes and dyslipidemiaJPRN-UMIN000032701Tokorozawa Heart Center30
已完成
不适用
Prospective, randomized, open-label,clinical trial comparing the effects of febuxostat and allopurinol on blood urate levels, endothelial function and makers for obesity/oxidative stress/chronic kidney diseasesHyperuricemiaJPRN-UMIN000011741ational Defense Medical College31
已完成
不适用
Prospective, randomized, open-label,clinical trial comparing the effects of amlodipine alone and irbesartan/amlodipine combination on blood pressure, endothelial function and makers for obesity/oxidative stress/chronic kidney diseasesHypertensionJPRN-UMIN000011725ational Defense Medical College30